Our range of services and technologies include:
- Immunology and immunogenicity assessment
- Antibody and protein engineering to reduce immunogenicity
- Bioconjugation to produce antibody drug conjugates and optimise pharmacokinetics
- Custom synthesis of cytotoxic payloads, reagents and other small molecules
- Manufacture of payload linkers and antibody drug conjugates
- Development of manufacturing cell lines and process development
- Manufacture of biopharmaceuticals for Phase I and II clinical studies